Stock Events

Stock Events

Kalvista Pharmaceuticals (KALV) Q1 2025 Earnings

12MarConfirmed

Q3 2024

Q3 2024

Q4 2024

Q1 2025

-1.02

-0.92

-0.82

-0.71

Details

Expected EPS

-0.866

Actual EPS

-0.92

Surprise EPS

-0.05

Surprise Percent

+6.24%

Description

Kalvista Pharmaceuticals (KALV) has reported earnings of -0.92 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.